| 1 |
Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of a-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study |
|
| | Takeshi Osonoi,Atsuko Tamasawa,Yusuke Osonoi,Kensuke Ofuchi,Makoto Katoh,Miyoko Saito | | | Diabetes Therapy. 2019; | | | [Pubmed] [Google Scholar] [DOI] | |
|
